Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy

Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy

Photoimmunotherapy is a novel cancer treatment that recently became covered by national health insurance in Japan, but treatment decision-making remains challenging for unresectable advanced or recurrent head and neck cancer. We aimed to clarify the characteristics of patients for whom photoimmunoth...

Full description

Bibliographic Details
Main Authors: Takeshi Shinozaki, Kazuto Matsuura, Wataru Okano, Toshifumi Tomioka, Yukio Nishiya, Michiko Machida, Ryuichi Hayashi
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
photoimmunotherapy
advanced head and neck cancer
timing of photoimmunotherapy
Online Access:https://www.mdpi.com/2072-6694/15/15/3795

Similar Items

Similar Items